Market Development Pattern And Forecast Of Animal Disease Diagnostic Reagents Industry In China

In the field of animal disease diagnostic reagents, Europe and the United States have great strength, South Korea is emerging, and China is still catching up. Professional diagnostic reagent companies in developed countries continue to emerge, such as American IDEXX Company, French LSI Company, South Korean Anigen Company, etc., all have stable diagnostic reagent products, and occupy a large proportion of China's commodity market share.

At present, under the background that veterinary vaccine production enterprises have entered the GMP era in China, there is a serious shortage of diagnostic reagent enterprises and production lines with GMP qualification in China. According to statistics, there are more than 2 500 veterinary drug enterprises with GMP qualification in China, among which only 6 are diagnostic reagent enterprises, and 12 diagnostic reagent production lines are set up by vaccine enterprises.

At present, the level of animal disease diagnosis technology in China is not clear, the research and development ability of diagnostic reagents is very weak, and the level of productization is very low, which is far from the actual demand. In the next 20 years, it is necessary to support the establishment of 2-3 innovative research and development platforms and 1 large-scale biological products production enterprise, and make significant breakthroughs in the two fields of new technology research and development and industrialization technology (basic process). It is necessary to research and develop a series of rapid diagnostic reagents, differential diagnostic reagents, detection reagents for evaluation of immune effect and high-throughput detection reagents based on the prevention and control plan of animal epidemic diseases, so as to effectively meet the needs of grassroots applications and occupy a place in the world